Evidence mapPaperPMID 40922860Full record

ReviewCureus2025

The Association of SARS-CoV-2 Infection and COVID-19 Vaccination With Sudden Death: An Explorative Review.

Sakshitha Potluri, Nethra Chittiprol, Vamshi Varaganti, Vishnu Avr, Sabitha Vadakedath, Deepthi Arvapally, Chaitanya Vemulapalli, Gulam Saidunnisa Begum, Naveen Madamsetti, Venkataramana Kandi

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sakshitha PotluriMedicine, Prathima Institute of Medical Sciences, Karimnagar, IND.
Nethra ChittiprolHealth Sciences, Cypress Bay High School, Weston, USA.
Vamshi VaragantiMedicine, Prathima Institute of Medical Sciences, Karimnagar, IND.
Vishnu AvrMedicine, Prathima Institute of Medical Sciences, Karimnagar, IND.
Sabitha VadakedathBiochemistry, Prathima Institute of Medical Sciences, Karimnagar, IND.
Deepthi ArvapallyMedicine, Prathima Institute of Medical Sciences, Karimnagar, IND.
Chaitanya VemulapalliRadiology, Emory Warner Robins /Houston Health Care, Warner Robins, USA.
Gulam Saidunnisa BegumBiochemistry, College of Medicine and Health Sciences, National University of Science and Technology, Sohar, OMN.
Naveen MadamsettiInhalation, Proveris Scientific Corporation, Hudson, USA.
Venkataramana KandiClinical Microbiology, Prathima Institute of Medical Sciences, Karimnagar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its discovery, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has become the epicenter of public health concern. This was mainly attributed to the complexity of COVID-19 that resulted in variable disease progression with some developing asymptomatic infections, some suffering mild to moderate infections that resolved without the need for hospitalizations, and a few infected persons developing severe infections that required intensive care unit (ICU) admission and mechanical ventilation. The COVID-19 pandemic spread globally, affecting billions of people and killing millions. Most of the consequences were related to the novelty of the virus, poor understanding of its pathogenesis, and the lack of a specific antiviral drug and vaccine. The vaccines, although manufactured and made available to the public, were approved for emergency use before the completion of human clinical trials. Moreover, the continuous emergence of viruses following mutations resulted in the emergence of viral variants. This has led to doubts over the efficacy of vaccines. Vaccine inequity, represented by the disproportionate availability and distribution of vaccines among the rich and poor, concerns over long-term safety, and hesitancy, affected COVID-19 vaccination, thereby increasing the spread of SARS-CoV-2. Although the COVID-19 pandemic is no longer considered a public health emergency of international concern (PHEIC), the repercussions of the pandemic are still evident in the form of long COVID and post-COVID functional health status (PCFHS), wherein individuals who were previously infected continue to suffer organ dysfunction, primarily affecting the lungs and other organs of the body. During and after the pandemic, COVID-19 and probably vaccination were attributed to the death of many individuals, which were categorized as sudden death (SD) and sudden unnatural death (SUD). It is unclear if these deaths were a result of previous SARS-CoV-2 infection and prior COVID-19 vaccination or both. There are several instances of infected and recovered individuals who were healthy but suddenly developed complications and died. Through this explorative review, we aim to comprehend the role that SARS-CoV-2 infection and/or COVID-19 vaccination play in predisposing people to cardiovascular system (CVS) and central nervous system (CNS) disorders that can result in SD and SUD.

Indexed as

cardiovascular system (cvs)central nervous system (cns)coronavirus disease-2019 (covid-19)covid-19 vaccinationsars-cov-2 infectionsevere acute respiratory syndrome coronavirus-2 (sars-cov-2)sudden death (sd)sudden unnatural death (sd)

Identifiers

PMID40922860
PMCPMC12414522

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.